e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis
J. Taytard, C. Rebeyrol, D. Debray, A. Clement, N. Chignard, P. Le Rouzic (Paris, France)
Source:
Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session:
Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session type:
Oral Presentation
Number:
366
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Taytard, C. Rebeyrol, D. Debray, A. Clement, N. Chignard, P. Le Rouzic (Paris, France). Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Oral contraceptives do not appear to affect cystic fibrosis disease severity
Source: Eur Respir J 2013; 41: 67-73
Year: 2013
Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2008; 31: 36-42
Year: 2008
Serum microRNA levels in paediatric females versus males with cystic fibrosis
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
Supressive antimicrobial therapy in chronic bronchial infection: the example of cystic fibrosis
Source: Annual Congress 2011 - Chronic bronchial infection: more than a syndrome
Year: 2011
Tolerance and efficacy of slow release octreotide in idiopathic pulmonary fibrosis. The FIBROSAND study
Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2010
Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003
Circulating inflammatory cytokines in adult cystic fibrosis patients
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005
Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
E-cadherin (
CDH-1
) polymorphisms associate with airway remodeling, inflammation and FEV
1
decline in asthma patients using inhaled corticosteroids (ICS)
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010
Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma
Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019
Year: 2019
Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept